The tankyrase‐specific inhibitor <scp>JW</scp>74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines
Eva W. Stratford(Oslo University Hospital), Ola Myklebost(Oslo University Hospital)
Cited by 61
Related Papers
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
|The Lancet Oncology|2016|213
Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma
|Cells|2019|20
The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition
|Frontiers in Immunology|2023|12